FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981672124> ?p ?o ?g. }

• W2981672124 endingPage "328" @default.
• W2981672124 startingPage "320" @default.
• W2981672124 abstract "Oral mucositis (OM) is a frequent and painful sequela of concomitant chemoradiation (CRT) used for the treatment of head and neck cancer (HNC) for which there is no effective intervention. This randomized, placebo-controlled study evaluated the efficacy of a novel, mucoadhesive topical tablet formulation of clonidine in mitigating CRT-induced OM in patients with HNC.Patients with HNC undergoing adjuvant radiation therapy (60-66 Gy; 5 × 1.8-2.2 Gy/wk) with concomitant platinum-based chemotherapy received daily local clonidine at 50 μg (n = 56), 100 μg (n = 65), or placebo (n = 62) via a topical mucobuccal tablet starting 1 to 3 days before and continuing during treatment. The primary endpoint was the incidence of severe OM (severe OM [SOM], World Health Organization grade 3/4).SOM developed in 45% versus 60% (P = .06) of patients treated with clonidine compared with placebo and occurred for the first time at 60 Gy as opposed to 48 Gy (median; hazard ratio, 0.75 [95% confidence interval, 0.484-1.175], P = .21); median time to onset was 45 versus 36 days. Opioid analgesic use, mean patient-reported mouth and throat soreness, and CRT compliance were not significantly different between treatment arms. Adverse events were reported in 90.8% versus 98.4%, nausea in 49.6% versus 71.0%, dysphagia in 32.8% versus 48.4%, and reversible hypotension in 6.7% versus 1.6% of patients on clonidine versus placebo, respectively.Although the primary endpoint was not met, the positive trends of OM-associated outcomes suggest that the novel mucoadhesive tablet delivery of clonidine might favorably affect the course and severity of CRT-induced SOM and support further evaluation." @default.
• W2981672124 created "2019-11-01" @default.
• W2981672124 creator A5001301524 @default.
• W2981672124 creator A5001462136 @default.
• W2981672124 creator A5001765593 @default.
• W2981672124 creator A5018624121 @default.
• W2981672124 creator A5021551704 @default.
• W2981672124 creator A5028274750 @default.
• W2981672124 creator A5045285437 @default.
• W2981672124 creator A5046156308 @default.
• W2981672124 creator A5051619763 @default.
• W2981672124 creator A5052773671 @default.
• W2981672124 creator A5053357127 @default.
• W2981672124 creator A5058288803 @default.
• W2981672124 creator A5061987454 @default.
• W2981672124 creator A5062963058 @default.
• W2981672124 creator A5065530824 @default.
• W2981672124 creator A5065766166 @default.
• W2981672124 creator A5069992341 @default.
• W2981672124 date "2020-02-01" @default.
• W2981672124 modified "2023-09-30" @default.
• W2981672124 title "Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer" @default.
• W2981672124 cites W1521460822 @default.
• W2981672124 cites W1690065136 @default.
• W2981672124 cites W1751408275 @default.
• W2981672124 cites W1808787828 @default.
• W2981672124 cites W1851570522 @default.
• W2981672124 cites W1921819744 @default.
• W2981672124 cites W1976971060 @default.
• W2981672124 cites W1999849764 @default.
• W2981672124 cites W2067089217 @default.
• W2981672124 cites W2086962186 @default.
• W2981672124 cites W2102116197 @default.
• W2981672124 cites W2124780554 @default.
• W2981672124 cites W2130382626 @default.
• W2981672124 cites W2141164707 @default.
• W2981672124 cites W2144367231 @default.
• W2981672124 cites W2167301149 @default.
• W2981672124 cites W2737577443 @default.
• W2981672124 cites W2907013729 @default.
• W2981672124 cites W3190697283 @default.
• W2981672124 cites W4235120723 @default.
• W2981672124 cites W4293241248 @default.
• W2981672124 doi "https://doi.org/10.1016/j.ijrobp.2019.10.023" @default.
• W2981672124 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31669562" @default.
• W2981672124 hasPublicationYear "2020" @default.
• W2981672124 type Work @default.
• W2981672124 sameAs 2981672124 @default.
• W2981672124 citedByCount "15" @default.
• W2981672124 countsByYear W29816721242020 @default.
• W2981672124 countsByYear W29816721242021 @default.
• W2981672124 countsByYear W29816721242022 @default.
• W2981672124 countsByYear W29816721242023 @default.
• W2981672124 crossrefType "journal-article" @default.
• W2981672124 hasAuthorship W2981672124A5001301524 @default.
• W2981672124 hasAuthorship W2981672124A5001462136 @default.
• W2981672124 hasAuthorship W2981672124A5001765593 @default.
• W2981672124 hasAuthorship W2981672124A5018624121 @default.
• W2981672124 hasAuthorship W2981672124A5021551704 @default.
• W2981672124 hasAuthorship W2981672124A5028274750 @default.
• W2981672124 hasAuthorship W2981672124A5045285437 @default.
• W2981672124 hasAuthorship W2981672124A5046156308 @default.
• W2981672124 hasAuthorship W2981672124A5051619763 @default.
• W2981672124 hasAuthorship W2981672124A5052773671 @default.
• W2981672124 hasAuthorship W2981672124A5053357127 @default.
• W2981672124 hasAuthorship W2981672124A5058288803 @default.
• W2981672124 hasAuthorship W2981672124A5061987454 @default.
• W2981672124 hasAuthorship W2981672124A5062963058 @default.
• W2981672124 hasAuthorship W2981672124A5065530824 @default.
• W2981672124 hasAuthorship W2981672124A5065766166 @default.
• W2981672124 hasAuthorship W2981672124A5069992341 @default.
• W2981672124 hasConcept C126322002 @default.
• W2981672124 hasConcept C141071460 @default.
• W2981672124 hasConcept C142724271 @default.
• W2981672124 hasConcept C168563851 @default.
• W2981672124 hasConcept C197934379 @default.
• W2981672124 hasConcept C203092338 @default.
• W2981672124 hasConcept C204787440 @default.
• W2981672124 hasConcept C27081682 @default.
• W2981672124 hasConcept C2776530083 @default.
• W2981672124 hasConcept C2778496288 @default.
• W2981672124 hasConcept C2779384505 @default.
• W2981672124 hasConcept C42219234 @default.
• W2981672124 hasConcept C509974204 @default.
• W2981672124 hasConcept C71924100 @default.
• W2981672124 hasConceptScore W2981672124C126322002 @default.
• W2981672124 hasConceptScore W2981672124C141071460 @default.
• W2981672124 hasConceptScore W2981672124C142724271 @default.
• W2981672124 hasConceptScore W2981672124C168563851 @default.
• W2981672124 hasConceptScore W2981672124C197934379 @default.
• W2981672124 hasConceptScore W2981672124C203092338 @default.
• W2981672124 hasConceptScore W2981672124C204787440 @default.
• W2981672124 hasConceptScore W2981672124C27081682 @default.
• W2981672124 hasConceptScore W2981672124C2776530083 @default.
• W2981672124 hasConceptScore W2981672124C2778496288 @default.
• W2981672124 hasConceptScore W2981672124C2779384505 @default.
• W2981672124 hasConceptScore W2981672124C42219234 @default.
• W2981672124 hasConceptScore W2981672124C509974204 @default.

• next